eCaseLink RTSM is an award-winning Randomization and Trial Supply Management system designed to manage randomization, subject enrollment, and drug supply in various clinical trial settings. It functions as a fully integrated component of the eCaseLink platform, aiming to provide the highest quality, clean data for both decentralized and traditional clinical trials. The system offers simple, cost-effective integration, drug accountability, data integration, rapid and flexible implementation, and ease of administering protocol deviations, leading to increased efficiency and productivity. It supports end-to-end supply chain management and can deliver average savings of over $100,000 per study. eCaseLink RTSM enables simplified randomization, participant enrollment, and drug supply management, with features including remote randomization, data integration, real-time access to data and reports, customized reporting, and readiness for risk-based monitoring. It also provides solutions for Drug-Device delivery, including Direct-to-Patient, Depot-to-Patient, Site-to-Patient, and Hybrid Solutions. The system can be used stand-alone or fully integrated with eCaseLink EDC software, automating patient randomization and providing web-based reporting. It reduces the need for costly IVR systems and optimizes inventory management by ensuring timely and accurate supply delivery through automated messaging triggered by low supply thresholds.

Features & Benefits

• Unified Platform: Integrates randomization, enrollment, and drug supply management for clinical trials.
• Cost Reduction & Efficiency: Delivers significant cost savings per study and increases operational efficiency.
• Supply Chain Management: Provides end-to-end management from depots to patients with automated inventory tracking.
• Flexible Implementation: Offers rapid and adaptable deployment for studies of any size.
• Data Quality & Access: Ensures high-quality data with real-time access to randomization and supply information.